Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Peter Kabos

Concepts (428)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
60
2026
2363
6.140
 Why?
Receptors, Estrogen
24
2026
400
3.160
 Why?
Estrogen Receptor alpha
6
2025
151
1.490
 Why?
Receptors, Progesterone
13
2025
243
1.470
 Why?
Brain Neoplasms
16
2026
1325
1.130
 Why?
Estradiol
4
2025
507
1.010
 Why?
Aging, Premature
1
2025
16
0.920
 Why?
High-Intensity Interval Training
1
2025
45
0.880
 Why?
Doxorubicin
4
2025
397
0.850
 Why?
Antibiotics, Antineoplastic
1
2025
139
0.850
 Why?
Antineoplastic Combined Chemotherapy Protocols
12
2025
1955
0.810
 Why?
Estrogens
8
2026
364
0.800
 Why?
Keratin-5
6
2022
44
0.790
 Why?
Triple Negative Breast Neoplasms
6
2023
216
0.750
 Why?
Breast Neoplasms, Male
3
2018
29
0.730
 Why?
Stem Cells
8
2006
621
0.710
 Why?
Biomarkers, Tumor
7
2022
1314
0.710
 Why?
Tetrahydronaphthalenes
1
2021
31
0.660
 Why?
Chromatin
1
2025
554
0.660
 Why?
Antineoplastic Agents, Hormonal
7
2025
192
0.650
 Why?
MCF-7 Cells
5
2025
131
0.640
 Why?
Neoplasm Metastasis
4
2020
688
0.640
 Why?
Immunoprecipitation
4
2020
147
0.630
 Why?
Drug Resistance, Neoplasm
5
2025
877
0.620
 Why?
Neurons
9
2026
1637
0.610
 Why?
Neoplastic Cells, Circulating
1
2020
80
0.610
 Why?
Brain Edema
2
2023
62
0.610
 Why?
Benzodiazepines
1
2021
168
0.600
 Why?
Female
62
2026
78137
0.580
 Why?
Radiosurgery
3
2023
398
0.570
 Why?
Carcinoma, Intraductal, Noninfiltrating
2
2017
61
0.570
 Why?
Epithelial-Mesenchymal Transition
1
2020
211
0.570
 Why?
Leukocytes, Mononuclear
2
2020
572
0.550
 Why?
Artifacts
2
2016
142
0.550
 Why?
Binding Sites
2
2025
1306
0.550
 Why?
Gene Expression Regulation, Neoplastic
11
2025
1437
0.520
 Why?
Gene Expression Profiling
7
2020
1762
0.520
 Why?
Fanconi Anemia Complementation Group N Protein
1
2017
4
0.510
 Why?
Polyadenylation
1
2017
41
0.510
 Why?
Protein Kinase Inhibitors
7
2025
969
0.500
 Why?
Neoplastic Stem Cells
7
2020
407
0.500
 Why?
High-Throughput Nucleotide Sequencing
4
2019
548
0.500
 Why?
Organoplatinum Compounds
1
2016
66
0.500
 Why?
Carcinogenesis
2
2020
227
0.490
 Why?
Cancer-Associated Fibroblasts
1
2016
23
0.490
 Why?
Piperazines
5
2025
378
0.470
 Why?
Humans
75
2026
144298
0.470
 Why?
Cell Line, Tumor
17
2026
3520
0.470
 Why?
Pyridines
6
2025
601
0.460
 Why?
Fluorouracil
1
2016
234
0.460
 Why?
CD146 Antigen
3
2021
38
0.450
 Why?
Mitochondrial Proteins
1
2017
262
0.450
 Why?
Microscopy, Electron, Scanning Transmission
1
2014
3
0.440
 Why?
Thrombocytopenia
1
2016
202
0.430
 Why?
Microwaves
1
2014
29
0.430
 Why?
Maytansine
1
2014
18
0.420
 Why?
Microscopy
1
2014
148
0.390
 Why?
Trastuzumab
5
2023
117
0.370
 Why?
Receptors, Cytoplasmic and Nuclear
1
2014
204
0.370
 Why?
Receptor, Fibroblast Growth Factor, Type 1
2
2026
58
0.370
 Why?
Progestins
6
2025
65
0.370
 Why?
Neoplasms, Hormone-Dependent
1
2012
33
0.360
 Why?
Tamoxifen
5
2025
191
0.360
 Why?
RNA-Binding Proteins
1
2016
461
0.360
 Why?
Antineoplastic Agents
4
2023
2194
0.360
 Why?
Analgesics, Opioid
1
2021
1142
0.360
 Why?
Tumor Microenvironment
4
2021
728
0.350
 Why?
RNA Polymerase III
2
2025
34
0.350
 Why?
Homeodomain Proteins
5
2018
523
0.350
 Why?
MicroRNAs
5
2016
689
0.350
 Why?
Chemotherapy, Adjuvant
5
2023
425
0.330
 Why?
RNA
2
2016
926
0.330
 Why?
Repressor Proteins
2
2025
428
0.330
 Why?
Cancer Survivors
2
2026
330
0.320
 Why?
Neoplasm Recurrence, Local
5
2021
1143
0.320
 Why?
Mutation
3
2021
4068
0.320
 Why?
Neoadjuvant Therapy
3
2021
461
0.310
 Why?
Image Processing, Computer-Assisted
1
2014
778
0.310
 Why?
Antibodies, Monoclonal, Humanized
2
2021
989
0.300
 Why?
Tumor Cells, Cultured
7
2020
881
0.300
 Why?
Astrocytes
6
2026
228
0.290
 Why?
Pyrimidines
3
2018
518
0.290
 Why?
Middle Aged
20
2026
35892
0.290
 Why?
Liver Neoplasms
1
2015
777
0.290
 Why?
Neoplasm Staging
5
2026
1460
0.280
 Why?
Carcinoma, Ductal, Breast
2
2020
88
0.280
 Why?
Hydrocephalus
3
2023
111
0.280
 Why?
Signal Transduction
6
2026
5182
0.280
 Why?
Colorectal Neoplasms
1
2016
847
0.280
 Why?
Prognosis
7
2021
4293
0.280
 Why?
Adenocarcinoma
1
2015
919
0.270
 Why?
Bone Marrow Cells
2
2014
320
0.260
 Why?
Aged
17
2025
25901
0.240
 Why?
Neural Cell Adhesion Molecules
1
2026
38
0.240
 Why?
Helix-Loop-Helix Motifs
2
2002
12
0.240
 Why?
Adult
20
2026
40408
0.240
 Why?
Necrosis
2
2019
243
0.230
 Why?
Fibroblast Growth Factor 2
1
2026
93
0.230
 Why?
Aged, 80 and over
7
2025
8265
0.230
 Why?
Cluster Analysis
4
2019
516
0.230
 Why?
Chondroitin Sulfate Proteoglycans
2
2006
10
0.230
 Why?
Sequence Analysis, RNA
2
2019
441
0.220
 Why?
Fatty Acid Synthase, Type I
1
2025
11
0.220
 Why?
STAT1 Transcription Factor
1
2025
66
0.220
 Why?
Protein Binding
2
2025
2241
0.220
 Why?
Neuroglia
2
2003
173
0.220
 Why?
Neoplasm Grading
2
2017
310
0.210
 Why?
Weight Reduction Programs
1
2026
138
0.210
 Why?
RNA, Transfer
1
2025
144
0.210
 Why?
Mice, Inbred NOD
5
2021
608
0.210
 Why?
Genetic Therapy
2
2003
313
0.210
 Why?
Animals
28
2026
37800
0.210
 Why?
Aminopyridines
2
2025
127
0.210
 Why?
Carbolines
1
2024
35
0.200
 Why?
Disease-Free Survival
4
2024
768
0.200
 Why?
Aromatase Inhibitors
2
2021
74
0.200
 Why?
Triazines
1
2024
49
0.200
 Why?
Progesterone
3
2014
209
0.200
 Why?
Mice
20
2026
18218
0.200
 Why?
Obesity
3
2026
3068
0.200
 Why?
Benzimidazoles
2
2025
187
0.200
 Why?
Morpholines
1
2024
129
0.200
 Why?
Promoter Regions, Genetic
3
2025
1244
0.190
 Why?
Extracellular Matrix Proteins
1
2004
155
0.190
 Why?
Keratin-17
1
2022
4
0.190
 Why?
Aquaporin 4
2
2023
98
0.190
 Why?
Triglycerides
1
2025
517
0.190
 Why?
Nerve Regeneration
1
2002
58
0.190
 Why?
Tumor Suppressor Proteins
2
2015
318
0.180
 Why?
Mice, SCID
4
2020
368
0.180
 Why?
Stromal Cells
2
2020
119
0.180
 Why?
Down-Regulation
4
2015
613
0.180
 Why?
Glioma
5
2006
427
0.180
 Why?
Class I Phosphatidylinositol 3-Kinases
2
2025
108
0.180
 Why?
Cell-Free Nucleic Acids
1
2022
32
0.180
 Why?
Immunoconjugates
1
2023
138
0.180
 Why?
Neoplasm Invasiveness
3
2020
503
0.180
 Why?
Interleukin-13 Receptor alpha2 Subunit
1
2021
5
0.180
 Why?
Cyclins
1
2002
79
0.170
 Why?
Lipid Metabolism
1
2025
522
0.170
 Why?
Transcription, Genetic
2
2025
1465
0.170
 Why?
Overweight
1
2026
606
0.170
 Why?
Medicare
3
2023
888
0.170
 Why?
Tumor Suppressor Protein p53
2
2015
532
0.170
 Why?
Brain
3
2026
2929
0.160
 Why?
Insulin Receptor Substrate Proteins
1
2020
55
0.160
 Why?
Gene Regulatory Networks
2
2014
318
0.160
 Why?
Cell Adhesion Molecules
1
2021
178
0.160
 Why?
Disease Progression
5
2026
2844
0.160
 Why?
gamma-Aminobutyric Acid
1
2002
193
0.160
 Why?
Cancer Care Facilities
1
2020
48
0.160
 Why?
Meningeal Carcinomatosis
1
2020
7
0.160
 Why?
RNA, Messenger
3
2019
2808
0.150
 Why?
Antigens, Neoplasm
1
2021
271
0.150
 Why?
Hyaluronan Receptors
4
2014
100
0.150
 Why?
Retrospective Studies
6
2025
17104
0.150
 Why?
Cell Proliferation
6
2025
2485
0.150
 Why?
SEER Program
1
2021
226
0.150
 Why?
Gene Library
2
2019
123
0.150
 Why?
Carcinoma, Lobular
1
2020
55
0.150
 Why?
Antineoplastic Agents, Immunological
2
2019
201
0.150
 Why?
Collagen
2
2020
450
0.150
 Why?
Transcriptome
2
2019
1034
0.150
 Why?
Lymphatic Metastasis
2
2017
330
0.150
 Why?
ErbB Receptors
2
2020
626
0.140
 Why?
Treatment Outcome
6
2025
11713
0.140
 Why?
Paclitaxel
1
2020
254
0.140
 Why?
beta Catenin
1
2020
252
0.130
 Why?
Xenograft Model Antitumor Assays
4
2017
924
0.130
 Why?
Heterografts
4
2020
143
0.130
 Why?
3' Untranslated Regions
1
2017
150
0.120
 Why?
Feasibility Studies
2
2026
1098
0.120
 Why?
Pyrroles
1
2017
210
0.120
 Why?
Quinolines
3
2025
192
0.120
 Why?
Receptors, Androgen
1
2017
148
0.120
 Why?
Neoplasms, Radiation-Induced
1
2016
99
0.120
 Why?
Genital Neoplasms, Female
1
2017
99
0.120
 Why?
Gene Expression
2
2016
1474
0.120
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
971
0.110
 Why?
Neoplasms, Second Primary
1
2016
100
0.110
 Why?
Ovary
1
2017
226
0.110
 Why?
Single-Cell Analysis
1
2019
357
0.110
 Why?
Combined Modality Therapy
2
2019
1263
0.110
 Why?
Ribosomal Proteins
1
2015
91
0.110
 Why?
Proto-Oncogene Proteins c-akt
1
2017
435
0.110
 Why?
Paracrine Communication
1
2015
67
0.110
 Why?
DNA Primers
1
2016
507
0.110
 Why?
Cell Movement
4
2026
957
0.110
 Why?
Isoquinolines
2
2025
44
0.110
 Why?
Risk Reduction Behavior
1
2016
215
0.110
 Why?
Azetidines
2
2025
45
0.110
 Why?
Hodgkin Disease
1
2016
171
0.110
 Why?
Oxazoles
2
2025
48
0.110
 Why?
STAT5 Transcription Factor
1
2014
49
0.110
 Why?
Reactive Oxygen Species
1
2017
601
0.110
 Why?
Azepines
1
2015
106
0.110
 Why?
Pyrazoles
1
2018
510
0.100
 Why?
Fibroblasts
1
2020
1017
0.100
 Why?
Odds Ratio
1
2017
1076
0.100
 Why?
Receptors, Steroid
1
2014
41
0.100
 Why?
Microscopy, Atomic Force
1
2014
131
0.100
 Why?
Apoptosis
4
2017
2395
0.100
 Why?
Peptides
1
2020
985
0.100
 Why?
Clinical Decision-Making
1
2017
358
0.100
 Why?
Software
2
2019
689
0.100
 Why?
Quinazolines
2
2025
266
0.090
 Why?
CD24 Antigen
1
2012
18
0.090
 Why?
DNA-Binding Proteins
2
2015
1483
0.090
 Why?
Sensitivity and Specificity
2
2016
1990
0.090
 Why?
Retinoids
1
2012
33
0.090
 Why?
RNA Interference
1
2014
472
0.090
 Why?
Anthracyclines
2
2023
47
0.090
 Why?
Opioid-Related Disorders
1
2021
601
0.090
 Why?
Disease Models, Animal
4
2017
4525
0.090
 Why?
Taxoids
2
2023
115
0.090
 Why?
Cell Differentiation
4
2004
2033
0.090
 Why?
Comorbidity
1
2017
1652
0.090
 Why?
Clinical Trials as Topic
1
2017
1055
0.090
 Why?
Genome, Human
1
2014
419
0.090
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2012
173
0.090
 Why?
Small Molecule Libraries
1
2012
110
0.080
 Why?
Drug Discovery
1
2012
153
0.080
 Why?
Rats
5
2017
5553
0.080
 Why?
Tumor Burden
1
2012
323
0.080
 Why?
Male
8
2018
72263
0.080
 Why?
United States
4
2023
15979
0.080
 Why?
Logistic Models
1
2016
2112
0.080
 Why?
Mitochondria
1
2017
981
0.080
 Why?
Oligonucleotide Array Sequence Analysis
1
2012
749
0.080
 Why?
Estrogen Antagonists
1
2010
37
0.080
 Why?
Dendritic Cells
2
2004
496
0.080
 Why?
Nuclear Proteins
1
2015
739
0.080
 Why?
Time Factors
3
2020
7128
0.080
 Why?
Lung Neoplasms
1
2023
2643
0.080
 Why?
Transforming Growth Factor beta
1
2012
475
0.070
 Why?
BRCA2 Protein
1
2009
67
0.070
 Why?
Pregnancy Complications, Neoplastic
1
2009
63
0.070
 Why?
Administration, Oral
2
2024
847
0.070
 Why?
Cell Culture Techniques
2
2020
372
0.070
 Why?
Thrombophilia
1
2009
88
0.070
 Why?
Receptors, CXCR4
2
2006
91
0.070
 Why?
Practice Patterns, Physicians'
1
2017
1359
0.070
 Why?
Cells, Cultured
3
2006
4102
0.070
 Why?
Tumor Necrosis Factor-alpha
2
2002
1206
0.070
 Why?
Stem Cell Transplantation
3
2004
190
0.070
 Why?
Proteoglycans
2
2006
110
0.060
 Why?
Genetic Predisposition to Disease
1
2016
2348
0.060
 Why?
Immunohistochemistry
2
2017
1699
0.060
 Why?
Rats, Sprague-Dawley
2
2002
2512
0.060
 Why?
Radiotherapy, Adjuvant
2
2018
223
0.060
 Why?
Aurora Kinase A
2
2018
61
0.060
 Why?
Algorithms
1
2014
1839
0.060
 Why?
Risk Factors
2
2020
10783
0.060
 Why?
Drug Delivery Systems
1
2010
379
0.060
 Why?
Proof of Concept Study
1
2026
86
0.060
 Why?
Severity of Illness Index
1
2014
2917
0.060
 Why?
Biopsy
2
2020
1078
0.060
 Why?
Transcription Factor TFIIIB
1
2025
5
0.060
 Why?
TATA-Binding Protein Associated Factors
1
2025
22
0.060
 Why?
Nervous System
1
2006
69
0.060
 Why?
Rats, Inbred F344
2
2003
268
0.060
 Why?
Cyclin-Dependent Kinase 4
1
2025
53
0.060
 Why?
Mass Spectrometry
2
2020
741
0.060
 Why?
Cyclin-Dependent Kinase 6
1
2025
49
0.060
 Why?
Neoplasm Transplantation
2
2016
246
0.060
 Why?
Tomography, X-Ray Computed
1
2015
2741
0.050
 Why?
Infant, Premature, Diseases
1
2006
112
0.050
 Why?
Receptor-Like Protein Tyrosine Phosphatases, Class 5
1
2004
1
0.050
 Why?
Aggrecans
1
2004
15
0.050
 Why?
Purines
1
2025
187
0.050
 Why?
Lectins, C-Type
1
2004
59
0.050
 Why?
Cyclophosphamide
2
2018
265
0.050
 Why?
Maximum Tolerated Dose
1
2024
211
0.050
 Why?
Cell Line
2
2014
2821
0.050
 Why?
Hemangioma, Cavernous, Central Nervous System
1
2003
8
0.050
 Why?
Mastectomy, Segmental
2
2017
107
0.050
 Why?
Adipose Tissue
2
2018
643
0.050
 Why?
Aromatase
1
2023
32
0.050
 Why?
Follow-Up Studies
2
2025
5404
0.050
 Why?
Inhibitor of Differentiation Protein 2
1
2002
5
0.050
 Why?
Bridged-Ring Compounds
1
2023
30
0.050
 Why?
Inhibitor of Differentiation Protein 1
1
2002
8
0.050
 Why?
Glioblastoma
2
2006
353
0.050
 Why?
Camptothecin
1
2023
138
0.050
 Why?
Edema
1
2023
123
0.050
 Why?
Neoplasms, Multiple Primary
1
2003
58
0.050
 Why?
Hepatocyte Nuclear Factor 3-alpha
1
2022
9
0.050
 Why?
Pyramidal Tracts
1
2002
30
0.050
 Why?
Mice, Inbred C57BL
5
2004
5954
0.050
 Why?
Sciatic Nerve
1
2002
62
0.050
 Why?
Neurites
1
2002
50
0.050
 Why?
Vimentin
1
2022
54
0.050
 Why?
Gonadotropin-Releasing Hormone
1
2024
212
0.050
 Why?
Transcription Factor HES-1
1
2002
5
0.050
 Why?
Interleukin-12
1
2002
117
0.040
 Why?
Phenotype
1
2010
3139
0.040
 Why?
Blotting, Western
1
2004
1160
0.040
 Why?
Frontal Lobe
1
2002
159
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2002
106
0.040
 Why?
Oligonucleotides, Antisense
1
2002
116
0.040
 Why?
Mice, Inbred BALB C
1
2004
1246
0.040
 Why?
Fibroblast Growth Factors
1
2002
188
0.040
 Why?
Ependymoma
1
2003
176
0.040
 Why?
Protein-Lysine 6-Oxidase
1
2020
14
0.040
 Why?
Clinical Trials, Phase I as Topic
1
2020
50
0.040
 Why?
Cerebral Cortex
1
2004
470
0.040
 Why?
TOR Serine-Threonine Kinases
1
2024
452
0.040
 Why?
Hospitals, University
1
2021
176
0.040
 Why?
Nucleosomes
1
2022
164
0.040
 Why?
Weight Loss
1
2026
838
0.040
 Why?
Nervous System Diseases
1
2003
283
0.040
 Why?
Neoplasms
1
2015
2860
0.040
 Why?
Animals, Newborn
1
2002
888
0.040
 Why?
Adherens Junctions
1
2020
24
0.040
 Why?
Membrane Glycoproteins
1
2002
495
0.040
 Why?
Dose-Response Relationship, Drug
1
2024
2012
0.040
 Why?
Gene Knockout Techniques
1
2020
115
0.040
 Why?
Protein Interaction Mapping
1
2020
106
0.040
 Why?
Patient Acceptance of Health Care
1
2026
880
0.040
 Why?
Interferon-gamma
1
2002
781
0.040
 Why?
Kaplan-Meier Estimate
1
2021
966
0.040
 Why?
Mice, Nude
2
2015
677
0.040
 Why?
DNA, Complementary
1
2019
272
0.040
 Why?
beta-Galactosidase
3
2002
76
0.040
 Why?
Loss of Function Mutation
1
2018
46
0.030
 Why?
Maintenance Chemotherapy
1
2018
42
0.030
 Why?
Cadherins
1
2020
200
0.030
 Why?
Immunotherapy
1
2003
659
0.030
 Why?
Nausea
1
2018
111
0.030
 Why?
Wnt Signaling Pathway
1
2020
210
0.030
 Why?
Breast
1
2018
157
0.030
 Why?
Phenylthiohydantoin
1
2017
44
0.030
 Why?
Diarrhea
1
2018
192
0.030
 Why?
Mammary Neoplasms, Experimental
1
2017
62
0.030
 Why?
Mastectomy
1
2018
174
0.030
 Why?
Area Under Curve
1
2017
328
0.030
 Why?
Antigens, CD
1
2020
552
0.030
 Why?
Ovariectomy
1
2017
163
0.030
 Why?
Steroids
1
2017
159
0.030
 Why?
Benzamides
1
2017
224
0.030
 Why?
Cell Membrane
1
2020
704
0.030
 Why?
Nitriles
1
2017
204
0.030
 Why?
Fatigue
1
2018
363
0.030
 Why?
Flow Cytometry
2
2012
1152
0.030
 Why?
Apoptosis Regulatory Proteins
2
2009
185
0.030
 Why?
Proto-Oncogene Proteins c-mdm2
1
2015
67
0.030
 Why?
Chromatography, Liquid
1
2017
444
0.030
 Why?
Tumor Protein p73
1
2015
18
0.030
 Why?
Postmenopause
1
2017
390
0.030
 Why?
Gene Knockdown Techniques
1
2015
334
0.030
 Why?
Transcription Factors
1
2002
1726
0.030
 Why?
Molecular Targeted Therapy
1
2017
434
0.030
 Why?
Weight Gain
1
2018
557
0.030
 Why?
Serrate-Jagged Proteins
1
2014
27
0.030
 Why?
Jagged-1 Protein
1
2014
22
0.030
 Why?
Wnt-5a Protein
1
2014
24
0.030
 Why?
Argonaute Proteins
1
2014
31
0.030
 Why?
Matrix Metalloproteinase 2
1
2014
55
0.030
 Why?
Testosterone
1
2017
412
0.020
 Why?
Cell Transformation, Neoplastic
1
2015
337
0.020
 Why?
Cellular Microenvironment
1
2014
93
0.020
 Why?
Gene Expression Regulation
1
2022
2589
0.020
 Why?
Interleukin-6
1
2017
770
0.020
 Why?
Wnt Proteins
1
2014
133
0.020
 Why?
Guideline Adherence
1
2017
586
0.020
 Why?
Socioeconomic Factors
1
2017
1320
0.020
 Why?
Acitretin
1
2012
3
0.020
 Why?
Miconazole
1
2012
5
0.020
 Why?
Calcium-Binding Proteins
1
2014
220
0.020
 Why?
Isotretinoin
1
2012
26
0.020
 Why?
Intercellular Signaling Peptides and Proteins
1
2014
376
0.020
 Why?
Luciferases
1
2012
152
0.020
 Why?
Genes, Reporter
1
2012
272
0.020
 Why?
Tretinoin
1
2012
124
0.020
 Why?
Biomarkers
2
2017
4248
0.020
 Why?
Vascular Endothelial Growth Factor A
1
2014
549
0.020
 Why?
Risk Assessment
1
2020
3680
0.020
 Why?
Green Fluorescent Proteins
1
2012
402
0.020
 Why?
Proto-Oncogene Proteins
1
2014
619
0.020
 Why?
Diet
1
2018
1270
0.020
 Why?
Magnetic Resonance Imaging
2
2019
3879
0.020
 Why?
Base Sequence
1
2014
2171
0.020
 Why?
Colorado
1
2020
4554
0.020
 Why?
HEK293 Cells
1
2012
741
0.020
 Why?
Age Factors
1
2017
3324
0.020
 Why?
Hypertension
1
2018
1259
0.020
 Why?
Molecular Sequence Data
1
2014
2896
0.020
 Why?
Pregnancy Trimester, Second
1
2009
80
0.020
 Why?
Practice Guidelines as Topic
1
2017
1565
0.020
 Why?
Pregnancy Trimester, First
1
2009
136
0.020
 Why?
Lymph Node Excision
1
2009
173
0.020
 Why?
Endothelial Cells
1
2014
862
0.020
 Why?
Transplantation, Heterologous
1
2008
169
0.020
 Why?
Membrane Proteins
1
2014
1158
0.020
 Why?
Neoplasms, Experimental
1
2008
167
0.020
 Why?
CD8-Positive T-Lymphocytes
2
2002
914
0.010
 Why?
Chemokines, CXC
1
2006
68
0.010
 Why?
Nestin
1
2006
19
0.010
 Why?
Laminin
1
2006
70
0.010
 Why?
Intermediate Filament Proteins
1
2006
57
0.010
 Why?
CD4-Positive T-Lymphocytes
2
2002
1129
0.010
 Why?
Infant, Newborn
2
2009
6387
0.010
 Why?
Chemokine CXCL12
1
2006
86
0.010
 Why?
Lasers
1
2006
126
0.010
 Why?
Glial Fibrillary Acidic Protein
1
2006
125
0.010
 Why?
Drug Combinations
1
2006
392
0.010
 Why?
Adolescent
1
2024
22370
0.010
 Why?
Culture Media, Conditioned
1
2004
111
0.010
 Why?
RNA, Small Interfering
1
2006
629
0.010
 Why?
Injections, Intralesional
1
2003
35
0.010
 Why?
TNF-Related Apoptosis-Inducing Ligand
1
2002
54
0.010
 Why?
3T3 Cells
1
2002
156
0.010
 Why?
Random Allocation
1
2003
364
0.010
 Why?
Nerve Tissue Proteins
1
2006
590
0.010
 Why?
Models, Neurological
1
2004
250
0.010
 Why?
Adenoviridae
1
2002
199
0.010
 Why?
Reference Values
1
2003
793
0.010
 Why?
Infant, Premature
1
2006
612
0.010
 Why?
Genetic Vectors
1
2002
334
0.010
 Why?
Transfection
1
2002
922
0.010
 Why?
Oligodendroglia
1
2002
188
0.010
 Why?
Recombinant Fusion Proteins
1
2002
666
0.010
 Why?
Case-Control Studies
1
2006
3595
0.010
 Why?
Survival Rate
1
2003
2081
0.010
 Why?
Pregnancy
1
2009
7112
0.010
 Why?
Vaccination
1
2003
1416
0.010
 Why?
Prospective Studies
1
2006
7972
0.010
 Why?
Infant
1
2006
10011
0.010
 Why?
Kabos's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (428) concept(s)
_
Co-Authors Expand Description
See all (74) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)